Skip to main content
SpringerLink
Log in

Dünndarmerkrankungen

  • Chapter
Medizinische Therapie 2005|2006

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Literatur

  • Catassi C, Ratsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, Coppa GV, Giorgi PL (1994) Coeliac disease in the year 2000: exploring the iceberg. Lancet 343: 200–203

    Article  CAS  PubMed  Google Scholar 

  • Ciclitira P (2001) AGA technical review on celiac sprue. Gastroenterology 120: 1526–1540

    CAS  PubMed  Google Scholar 

  • Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3: 797–801

    Article  CAS  PubMed  Google Scholar 

  • Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, Sollid LM (1993) Gliadin-specific, HLA-DQ (alpha*0501, beta*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 178: 187–196

    Article  CAS  PubMed  Google Scholar 

  • Marsh MN (1992) Gluten, major histocompatibility complex, and the small intestine: A molecular and immunobiologic approach to the spectrum of gluten sensitivity („celiac sprue“). Gastroenterology 102: 330–354

    CAS  PubMed  Google Scholar 

  • Mustalahti K, Collin P, Sievanen H, Mäki M (1999) Osteopenia in patients with clinically silent celiac disease. Lancet 354: 744–745

    Article  CAS  PubMed  Google Scholar 

  • Schuppan D (2000) Novel concepts of coeliac disease pathogenesis. Gastro-enterology 119: 234–242

    CAS  Google Scholar 

  • Schuppan D, Hahn EG (2002) Gluten and the gut: lessons for immune regu-lation. Science 297: 22/8

    Article  Google Scholar 

  • Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E (1989) Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 169: 345–350

    Article  CAS  PubMed  Google Scholar 

  • Ventura A, Magazzu G, Greco L, and the SIGEP study group (1999) Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 117: 297–303

    Article  CAS  PubMed  Google Scholar 

Literatur

  • Caspary W (1996) Malassimilationssyndrome. In: Hahn EG, Riemann JF (Hrsg) Klinische Gastroenterologie, 3. Aufl. Thieme, Stuttgart, S 1889–1910

    Google Scholar 

  • Fedorak RN, Field M, Chang EB (1985) Treatment of diabetic diarrhea with clonidine. Ann Intern Med 102: 197–199

    CAS  PubMed  Google Scholar 

  • Iacono G, Caroccio A, Montalto G, Cavataio F, Balsamo V, Notarbartolo A (1991) Steatocrit test after a standard fatty meal: a new simple and sensitive test to detect malabsorption. J Pediatr Gastroenterol Nutr 13: 161–167

    CAS  PubMed  Google Scholar 

  • King CE, Toskes PP (1986) Comparison of the 1-gram 14C-xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small bowel bacterial overgrowth. Gastroenterology 91: 1447–1451

    CAS  PubMed  Google Scholar 

  • Raithel M, Hahn EG (1996) Qualitative und quantitative Funktionsdiagnostik von Magen und Darm. In: Hahn EG, Riemann JF (Hrsg) Klinische Gastroenterologie, 3. Aufl. Thieme, Stuttgart, S 101–109

    Google Scholar 

  • Stein J, Purschian B, Bienek U, Caspary WF, Lembcke B (1994) Near infrared reflectance analysis: a new dimension in the investigation of of malabsorption syndromes. Eur J Gastroenterol Hepatol 6: 889–894

    Google Scholar 

Literatur

  • Abell TL, Camilleri M, DiMagno EP et al. (1991) Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 36: 616–620

    Article  CAS  PubMed  Google Scholar 

  • Coulie B, Camilleri M (1999) Intestinal pseudo-obstruction. Annu Rev 116: 980–987

    Google Scholar 

  • Eagon JC, Soper NJ (1993) Gastrointestinal pacing. Surg Clin North 73: 1161–1172

    CAS  Google Scholar 

  • Emmanuel AV, Shand AG, Kamm A (2004) Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 19: 687

    Article  CAS  PubMed  Google Scholar 

  • Murr MM, Sarr MG, Camilleri M (1995) The surgeon’s role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol 90(12): 2147–2151

    CAS  PubMed  Google Scholar 

  • Parkman HP, Pagano AP, Vozzelli MA et al. (1995) Gastrokinetic effects of ery-thromycin: myogenic and neurogenic mechanisms of action in rabbit stomach. Am J Physiol 269: 418–426

    Google Scholar 

  • Perlemuter G, Cacoub P, Chaussade S et al (1999) Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases. Arthritis Rheum 42(7):1545–1549

    Article  CAS  PubMed  Google Scholar 

  • Schuffler MD, Rohrmann CA, Chaffee RG et al. (1981) Chronic intestinal pseudo-obstruction: a report of 27 cases and review of the literature. Medicine 60: 173–196

    CAS  PubMed  Google Scholar 

  • Shibata C, Naito H, Funayama Y et al. (2003) Surgical treatment of chronic intestinal pseudo-obstruction: report of three cases. Surg Today 33: 58–61

    Article  PubMed  Google Scholar 

  • Verne GN, Eaker EY, Hardy E, Sninsky CA (1995) Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis 40:1892–1901

    CAS  Google Scholar 

Literatur

  • Beau P, Labat-Labourdette J, Ingrand P, Beauchant M (1994) Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? J Hepatol 20(2): 240–244

    Article  CAS  PubMed  Google Scholar 

  • Byrne TA, Persinger RL, Young LS et al. (1995) A new treatment for patients with short bowel syndrome. Growth hormone, glutamine and a modified diet. Ann Surg 222: 243–247

    CAS  PubMed  Google Scholar 

  • Ellegard L, Bosaeus I, Nordgren S, Bengtson BA (1997) Low dose recom-binant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg 225: 88–93

    Article  CAS  PubMed  Google Scholar 

  • Feldman EJ, Dowling RH, McNaughton J (1976) Effects of oral versus intra-venous nutrition on intestinal adaptation after small bowel resection in the dog. Gastroenterology 70: 712

    CAS  PubMed  Google Scholar 

  • Feldman MB, Scharschmidt F, Sleisenger MH (eds) (1998) Gastrointestinal and liver disease, WB Saunders, Philadelphia, p 1548–1556

    Google Scholar 

  • Fischbein TM, Kaufmann SS, Florman SS et al. (2003) Isolated intestinal tranplantation: proof of clinical efficiency. Transplantation 76: 636–640

    Google Scholar 

  • Jeppesen PB, Blosch CM et al. (2002) Alx-0600, a dipeptidyl peptidase-IV resistant glukagon-like peptide-2 (GLP-2) analog, improves intestinal function in short-bowel syndrome (SBS) patients with a jejunostomy. Gastroenterology 122: S1249

    Google Scholar 

  • Kurkchubasche A, Rowe MI, Smith SD (1993) Adaptation in short-bowel syndrome: Reassessing old limits. J Pediatr Surg 28: 1069

    Article  CAS  PubMed  Google Scholar 

  • Lennard-Jones JE (1994) Review article: Practical management of the short bowel. Aliment Pharmacol Ther 8: 563

    CAS  PubMed  Google Scholar 

  • Riecken EO, Schulzke JD (1992) Zustand nach Resektion des Dünndarms. In: Goebell H (Hrsg) Innere Medizin der Gegenwart. Gastroenterologie, Teil D. Urban & Schwarzenberg, München Wien Baltimore

    Google Scholar 

  • Scolapio JS, Camilleri M, Fleming CR et al. (1997) Effect of growth hormone, glutamine, and diet on adaptation in short-bowelsyndrome: a randomized, controlled study. Gastroenterology 113: 1074–1079

    Article  CAS  PubMed  Google Scholar 

  • Spagnuolo MI, Iorio R, Vegnente A, Guarino A (1996) Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: A pilot study. Gastroenterology 111: 716

    Article  CAS  PubMed  Google Scholar 

  • Vanderhoof JA, Langnas AN, Pinch LW et al. (1992) Invited review: Short bowel syndrome. J Pediatr Gastroenterol Nutr 14: 359

    CAS  PubMed  Google Scholar 

Literatur

  • Arnold R, Simon B, Wied M (2000) Treatment of neuroendocrine GEP tumours with somatostatin analogues. Digestion 62(Suppl 1): 84–91

    CAS  PubMed  Google Scholar 

  • Coit GC (2001) Cancer of the small intestine. In: De Vita VT, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology. JB Lippincott, Philadelphia, pp 1204–1216

    Google Scholar 

  • Faiss S, Pape UF, Bohmig M et al. (2003) Prospective, randomized trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroentero-pancreatic tumors. J Clin Oncol 21: 2689–2696

    Article  CAS  PubMed  Google Scholar 

  • Guillausseau PJ, Guillausseau-Scholer C (1995) Glucagonomas: Clinical presentation, diagnosis, and advance in management. In: Mignon M, Jensen RT (eds) Endocrine tumors of the pancreas. Front Gastrointest 232:183–193

    Google Scholar 

  • Howe JR, Karnell LH, Scott-Conner C (2001) Small bowel sarcoma: analysis of survival from the National Cancer Data Base. Ann Surg Onco 8: 496–508

    CAS  Google Scholar 

  • Klöppel G, Heitz PU (1988) Pancreatic endocrine tumors. Pathol Res Pract 183: 155–168

    PubMed  Google Scholar 

  • Lagergren J, Ye W, Ekbom A (2001) Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis. Gastroenterology 121: 542–547

    Article  CAS  PubMed  Google Scholar 

  • Matuschansky C, Rambaud JC (1995) VIPomas and endocrine cholera. Clinical presemtation, diagnosis, and advances in management. In: Mignon M, Jensen RT (eds) Endocrine tumors of the pancreas: Recent advances in research and management. Karger, Basel, pp 166–182

    Google Scholar 

  • Moertel CG, Kvols LK, O’Connell MJ, Rubin J (1991) Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Cancer 68: 227–232

    CAS  PubMed  Google Scholar 

  • Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D (1992) Streptozocin-Doxorubicin, Streptozocin-Fluorouracil, or Chlorozotocin in the treatment of advanced islet-cell carcinoma. New Engl J Med 326: 519–523

    CAS  PubMed  Google Scholar 

  • Öberg K (2001) Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 12(Suppl 2): 111–114

    Google Scholar 

  • Van Osterom, AT, Judson I, Verweij J et al. (2001) ST1571, an active drug in metastatic gastrointestinal stromal tumors (GIST), an EORTC phase 1 study. Proc Am Soc Clin Oncol 3: Abstract 37

    Google Scholar 

  • Venook AP (1999) Embolization and chemoembolization therapy for neuroendocrine tumors. Curr Opin Oncol 11: 38–41

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. Christoph Beglinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Detlef Schuppan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jörg Willert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stephan Hollerbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas Südhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wolff-H. Schmiegel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität Regensburg, D-93042, Regensburg

    Jürgen Schölmerich

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Beglinger, C., Schuppan, D., Willert, J., Hollerbach, S., Südhoff, T., Schmiegel, WH. (2005). Dünndarmerkrankungen. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_69

Download citation

  • DOI: https://doi.org/10.1007/3-540-27385-9_69

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21226-3

  • Online ISBN: 978-3-540-27385-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation